Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name file name title title previous answer version answering member constituency answering member printed answering member label attachment file name title
tabling member	label

Search

105978

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many Instant Rewards of what value were given to his Department's officials in (a) 2013 and (b) 2014 to date.
	tabling member constituency	Barrow and Furness
	tabling member printed	John Woodcock
	uin	213068
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p><del class="ministerial">The Civil Service Commission publish details of appointments made by exception and approved by them in their annual reports and on their website. These reports are available in the Library.</del></p><p><br /><del class="ministerial">It would not be appropriate to publish details of the requests turned down by the Commission as the numbers involved are small, and the individuals might be personally identified, directly or in combination with other published information.</del></p><p> </p><p><ins class="ministerial">The Department does not operate an ‘Instant Rewards’ scheme. The Department does, however, operate an in-year bonus scheme, which has strict criteria, approval processes and budgetary control.</ins></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 10/11/2014 16:58:06 question first ministerially corrected 10/11/2014 17:38:55 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 27280 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	3917 label Biography information for Lord Walney

169515

	registered interest
	date	10/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Professions: Regulation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what amount each of the healthcare regulators charged for annual registration fees in each of the last five years.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	218058
	answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The regulatory bodies are independent and it is therefore for them to set their fees appropriately. All professional regulators, are aware of the Governments position, as set out in the 2011 Command Paper, `Enabling Excellence’, that we would not expect registration fees to increase, unless there is a clear and strong case that any increase is essential to ensure the exercise of statutory duties.</p><p> </p><p>There are eight Healthcare Professions Regulatory Bodies (excluding the Pharmaceutical Society in Northern Ireland where responsibility is devolved to the Northern Ireland Assembly). The Department does not hold information on the fees of the regulatory bodies. However, we have obtained data from each of the regulatory bodies on the Annual Retention Fee for the last five years which shows:</p><p> </p><p> </p><p>Annual Retention Fee for Healthcare Professions Regulatory Bodies 2010-2015</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Nursing and Midwifery Council</p></td><td><p>Health and Care Professions Council</p></td><td><p>General Optical Council</p></td><td><p>General Medical Council</p></td><td><p>General Osteopathic Council</p></td><td><p>General Pharmaceutical Council</p></td><td><p>General Dental Council</p></td><td><p>General Chiropractic Council</p></td></tr><tr><td><p>2014-15</p></td><td><p>£100</p></td><td><p>£80</p></td><td><p>£290</p></td><td><p>£390</p></td><td><p>£570</p></td><td><p>£240</p></td><td><p>£576</p></td><td><p>£800</p></td></tr><tr><td><p>2013-14</p></td><td><p>£100</p></td><td><p>£76</p></td><td><p>£260</p></td><td><p>£390</p></td><td><p>£610</p></td><td><p>£240</p></td><td><p>£576</p></td><td><p>£800</p></td></tr><tr><td><p>2012-13</p></td><td><p>£76</p></td><td><p>£76</p></td><td><p>£260</p></td><td><p>£390</p></td><td><p>£655</p></td><td><p>£240</p></td><td><p>£576</p></td><td><p>£800</p></td></tr><tr><td><p>2011-12</p></td><td><p>£76</p></td><td><p>£76</p></td><td><p>£270</p></td><td><p>£390</p></td><td><p>£750</p></td><td><p>£267</p></td><td><p>£576</p></td><td><p>£800</p></td></tr><tr><td><p>2010 -11</p></td><td><p>£76</p></td><td><p>£76</p></td><td><p>£280 (Dispensing optician)</p><p>£325 (Optometrist)</p></td><td><p>£420</p></td><td><p>£750</p></td><td><p>£262</p></td><td><p>£438</p></td><td><p>£1,000</p></td></tr></tbody></table><p> </p><p> </p><p>The Department does not hold data on the number of investigations that have been carried out by each of the healthcare professions regulatory bodies. We understand that this information is published by each of the regulatory bodies.</p><p> </p><p>The Department has five national bodies which have regulatory functions. They are the Care Quality Commission, Monitor, the Human Fertilisation and Embryology Authority, the Human Tissue Authority and the Medicines and Healthcare products Regulatory Agency. None of these bodies charge an annual registration fee but <ins class="ministerial">all except Monitor </ins><del class="ministerial">they do</del> receive income from a range of fees that are applied.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 15/12/2014 17:43:27 question first ministerially corrected 18/12/2014 14:09:00 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 33732 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1503 label Biography information for Mr Jamie Reed

170098

	registered interest
	date	12/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Public Relations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much (a) NHS England, (b) Public Health England, (c) Monitor and (d) the Care Quality Commission spent on public relations and communications staff in (i) each year since 2010 and (ii) 2014 to date.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	218532
	answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>Below are details of how much each of the four bodies has spent on public relations and communications staff since 2010 or from when the data are available.</p><p> </p><p> </p><p> </p><p>To ensure consistency all organisations have provided data according to the following criteria for public relations (PR) and communications staff:</p><p> </p><p> </p><p> </p><p>- Press and PR</p><p> </p><p>- Stakeholder relations</p><p> </p><p>- Campaigns (not behaviour change policy)</p><p> </p><p>- Digital Comms (not IT/digital service teams)</p><p> </p><p>- Internal Comms</p><p> </p><p> </p><p> </p><p>(a) NHS England</p><p> </p><p> </p><p> </p><p>On 1 October 2012, the functions of the Board Authority transferred to the NHS Commissioning Board (also known as NHS England), which was formally established as an executive non departmental public body. NHS England took on all of its statutory functions in April 2013. Figures have been given from 1 October 2012.</p><p> </p><p> </p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>NHS England</p></td><td><p>2012/13</p><p>(October – April)</p></td><td><p>2013/14</p><p>(April – March)</p></td><td><p>2014/15</p><p>(April – November)</p></td></tr><tr><td><p>National Communications</p></td><td><p>£253,963</p></td><td><p>£584,419</p></td><td><p>£1,040,240</p></td></tr><tr><td><p>Communications in local areas</p></td><td> </td><td><p>£3,558,677</p></td><td><p>£2,595,881</p></td></tr><tr><td><p>NHS Improving Quality (NHS IQ)</p></td><td> </td><td><p>£325,265</p></td><td><p>£461,232</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>(b) Public Health England (PHE)</p><p> </p><p> </p><p> </p><p>PHE was formed on 1 April 2013 - figures from predecessor bodies are not provided.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Public Health England</p></td><td><p>2013/14</p></td><td><p>2014/15</p><p>(to November)</p></td></tr><tr><td><p>PR and Communications staff expenditure</p></td><td><p>£2,888,000</p></td><td><p>£2,323,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>(c) Monitor</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Monitor</p></td><td><p>2010<del class="ministerial">/11</del></p><p>(April – December)</p></td><td><p>2011<del class="ministerial">/12</del></p></td><td><p>2012<del class="ministerial">/13</del></p></td><td><p>2013<del class="ministerial">/14</del></p></td><td><p>2014<del class="ministerial">/15</del></p><p>(to November)</p></td></tr><tr><td><p>PR and Communications staff expenditure</p></td><td><p>£398,973.20</p><p> </p></td><td><p>£526,784.85</p></td><td><p>£486,320.81</p></td><td><p>£1,066,790.92</p></td><td><p>£1,223,775.43</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>(d) Care Quality Commission (CQC)</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>CQC</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td><td><p>2014/15</p><p>(to November)</p></td></tr><tr><td><p>PR and Communications staff expenditure</p></td><td><p>£568,951</p></td><td><p>£736,238</p></td><td><p>£1,188,519</p></td><td><p>£1,039,669</p></td><td><p>£780,195</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 05/01/2015 15:28:13 question first ministerially corrected 07/01/2015 11:11:25 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 36869 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1506 label Biography information for Andrew Gwynne

172236

	registered interest
	date	06/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer to Question 219055, which areas are piloting enhanced access to mental health practitioners.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	219813
	answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>All NHS 111 areas receive mental health calls and use algorithms within NHS Pathways to enable assessment; receiving additional support from nurses as required.</p><p> </p><p> </p><p> </p><p>There are <del class="ministerial">four</del> <ins class="ministerial">six </ins>areas that are piloting enhanced access to mental health practitioners, either within the NHS 111 call centre or by transferring to teams outside. NHS England is in the process of finalising which locations will take forward the NHS 111 pilot areas and NHS England will make an announcement when this process has been completed.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 09/01/2015 13:44:16 question first ministerially corrected 03/02/2015 11:25:01 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 37717 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	4036 label Biography information for Luciana Berger

173929

	registered interest
	date	15/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accident and Emergency Departments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many vacant A&E consultant posts there were in the NHS excluding London (a) on the most recent date for which figures are available and (b) in each of the previous six years.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Dame Tessa Jowell
	uin	220878
	answer	answer is ministerial correction date of answer 20/01/2015 answer text <p>Information on vacancies is not collected by the Department. The last annual National Health Service vacancy survey in England was undertaken by the Health and Social Care Information Centre in 2010. The survey was suspended in 2011 and then discontinued in 2013 following the publication of the Fundamental Review of Data Returns, which aimed to reduce the burden of the collection of data from NHS organisations.</p><p> </p><p> </p><p> </p><p>The attached table provides vacancy data for 2009 and 2010, the only two years within the last six years for which data is available.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 20/01/2015 16:08:26 question first ministerially corrected 20/01/2015 16:16:23 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name Table PQ220878 Vacancy data.xlsx title Vacancy data 2009-10 A&E Consultants previous answer version 39309 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	159 label Biography information for Baroness Jowell

173930

	registered interest
	date	15/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accident and Emergency Departments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many vacant A&E consultant posts there are in (a) London and (b) England; and how many such vacant posts there are in each category in each of the last six years.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Dame Tessa Jowell
	uin	220879
	answer	answer is ministerial correction date of answer 20/01/2015 answer text <p>Information on vacancies is not collected by the Department. The last annual National Health Service vacancy survey in England was undertaken by the Health and Social Care Information Centre in 2010. The survey was suspended in 2011 and then discontinued in 2013 following the publication of the Fundamental Review of Data Returns, which aimed to reduce the burden of the collection of data from NHS organisations.</p><p> </p><p> </p><p> </p><p>The attached table provides vacancy data for 2009 and 2010, the only two years within the last six years for which data is available.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 20/01/2015 16:08:26 question first ministerially corrected 20/01/2015 16:55:53 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name Table PQ220878 Vacancy data.xlsx title Vacancy data 2009-10 A&E Consultants previous answer version 39310 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	159 label Biography information for Baroness Jowell

224722

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mid Staffordshire NHS Foundation Trust
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what (a) public dividend capital and (b) other non-tariff payments have been made to the Mid-Stafforshire NHS Foundation Trust in (i) 2009-10, (ii) 2010-11, (iii) 2011-12, (iv) 2012-13, (v) 2013-14 and (vi) 2014-15 to date.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	225961
	answer	answer is ministerial correction date of answer 10/03/2015 answer text <p>The Department holds records of the total capital allocated to the respective recipient bodies as a result of the transfer of Mid-Staffordshire NHS Foundation Trust services but does not have details of the breakdown by individual hospital site.</p><p> </p><p> </p><p> </p><p>The capital provided to date is as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>The Royal Wolverhampton NHS Trust</p></td><td><p>£12,109,000</p></td></tr><tr><td><p>University Hospitals of North Midlands NHS Trust</p></td><td><p>£12,153,000</p></td></tr><tr><td><p>Walsall Healthcare NHS Trust</p></td><td><p>£4,000,000</p></td></tr><tr><td><p>Grand Total</p></td><td><p>£28,262,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Revenue funding provided to date is set out in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p><del class="ministerial">The Royal Wolverhampton NHS Trust</del></p><p><ins class="ministerial">University Hospitals of North Midlands NHS Trust</ins></p><p> </p></td><td><p>£32,420,000</p></td></tr><tr><td><p><del class="ministerial">University Hospitals of North Midlands NHS Trust</del></p><p><ins class="ministerial">The Royal Wolverhampton NHS Trust</ins></p></td><td><p>£5,480,000</p></td></tr><tr><td><p>Grand Total</p></td><td><p>£37,900,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The amount of public dividend capital issued to the Trust by the Department is as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>2009/10</p></td><td><p>£214,000</p></td></tr><tr><td><p>2010/11</p></td><td><p>£0</p></td></tr><tr><td><p>2011/12</p></td><td><p>£21,000,000</p></td></tr><tr><td><p>2012/13</p></td><td><p>£21,385,000</p></td></tr><tr><td><p>2013/14</p></td><td><p>£30,397,000</p></td></tr><tr><td><p>2014/15</p></td><td><p>£64,425,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The Department does not hold central records of non-tariff payments made by local commissioning bodies to NHS providers.</p><p> </p><p> </p><p> </p><p>The work of the trust special administrators (TSAs) to secure safe and sustainable services at Mid Staffordshire NHS Trust cost Monitor almost £19.5 million, including VAT, over 18 months.</p><p> </p><p> </p><p> </p><p>The first phase of trust special administration cost £9 million, including expenses and VAT. During this phase there was a team of up to 30 members of staff who carried out three core tasks - to help to run the Trust, to design the future of services provided at Stafford and Cannock hospitals, and to run a large public consultation involving thousands of responses and a series of public meetings.</p><p> </p><p> </p><p> </p><p>The second phase cost £10.5 million, including expenses and VAT. We are informed by Monitor that this second phase included a team of up to 50 people, which was required to continue to help run the hospital and implement the TSA’s recommendations.</p><p> </p><p> </p><p> </p><p>We are also informed by Monitor that trust special administration at Mid-Staffordshire NHS Trust amounted to the rounded figure of 10,900 person-days for teams working on both phases of the process.</p><p> </p><p> </p><p> </p><p>In the table below, expenses incurred during the TSA process are split by the two phases of the TSA and totals are also provided. These expenses include:</p><p> </p><p> </p><p> </p><p>(a) accommodation;</p><p> </p><p>(b) travel (car, taxi and train);</p><p> </p><p>(c) subsistence; and</p><p> </p><p>(d) other expenses incurred; and what other costs to the TSA were incurred</p><p> </p><p> </p><p> </p><p>Breakdown of expenses, these exclude VAT:</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td><p>TSA1</p></td><td><p>TSA2</p></td><td><p>Total</p></td></tr><tr><td><p>Accommodation</p></td><td><p>£82,242.89</p></td><td><p>£170,622.67</p></td><td><p>£252,865.56</p></td></tr><tr><td><p>Travel</p></td><td><p>£144,122.38</p></td><td><p>£226,600.29</p></td><td><p>£370,722.67</p></td></tr><tr><td><p>Subsistence</p></td><td><p>£16,171.73</p></td><td><p>£43,176.88</p></td><td><p>£59,348.61</p></td></tr><tr><td><p>Other (incidentals such as printing, room hire and meeting refreshments)</p></td><td><p>£1,939.11</p></td><td><p>£3052.73</p></td><td><p>£4991.84</p></td></tr><tr><td><p>Total</p></td><td><p>£244,476.11</p></td><td><p>£443,452.57</p></td><td><p>£687,928.68</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 10/03/2015 17:13:10 question first ministerially corrected 17/03/2015 16:58:22 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 49060 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	4109 label Biography information for Jeremy Lefroy

224723

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mid Staffordshire NHS Foundation Trust
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many consultants have been employed by the Trust Special Administration (TSA) of the Mid-Staffordshire NHS Foundation Trust since its inception; how many person-days they have worked; what (a) accommodation, (b) travel, (c) subsistence and (d) other expenses they have incurred; and what other costs to the TSA they have incurred.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	225962
	answer	answer is ministerial correction date of answer 10/03/2015 answer text <p>The Department holds records of the total capital allocated to the respective recipient bodies as a result of the transfer of Mid-Staffordshire NHS Foundation Trust services but does not have details of the breakdown by individual hospital site.</p><p> </p><p> </p><p> </p><p>The capital provided to date is as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>The Royal Wolverhampton NHS Trust</p></td><td><p>£12,109,000</p></td></tr><tr><td><p>University Hospitals of North Midlands NHS Trust</p></td><td><p>£12,153,000</p></td></tr><tr><td><p>Walsall Healthcare NHS Trust</p></td><td><p>£4,000,000</p></td></tr><tr><td><p>Grand Total</p></td><td><p>£28,262,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Revenue funding provided to date is set out in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p><del class="ministerial">The Royal Wolverhampton NHS Trust</del></p><p><ins class="ministerial">University Hospitals of North Midlands NHS Trust</ins></p></td><td><p>£32,420,000</p></td></tr><tr><td><p><del class="ministerial">University Hospitals of North Midlands NHS Trust</del></p><p><ins class="ministerial">The Royal Wolverhampton NHS Trust</ins></p></td><td><p>£5,480,000</p></td></tr><tr><td><p>Grand Total</p></td><td><p>£37,900,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The amount of public dividend capital issued to the Trust by the Department is as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>2009/10</p></td><td><p>£214,000</p></td></tr><tr><td><p>2010/11</p></td><td><p>£0</p></td></tr><tr><td><p>2011/12</p></td><td><p>£21,000,000</p></td></tr><tr><td><p>2012/13</p></td><td><p>£21,385,000</p></td></tr><tr><td><p>2013/14</p></td><td><p>£30,397,000</p></td></tr><tr><td><p>2014/15</p></td><td><p>£64,425,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The Department does not hold central records of non-tariff payments made by local commissioning bodies to NHS providers.</p><p> </p><p> </p><p> </p><p>The work of the trust special administrators (TSAs) to secure safe and sustainable services at Mid Staffordshire NHS Trust cost Monitor almost £19.5 million, including VAT, over 18 months.</p><p> </p><p> </p><p> </p><p>The first phase of trust special administration cost £9 million, including expenses and VAT. During this phase there was a team of up to 30 members of staff who carried out three core tasks - to help to run the Trust, to design the future of services provided at Stafford and Cannock hospitals, and to run a large public consultation involving thousands of responses and a series of public meetings.</p><p> </p><p> </p><p> </p><p>The second phase cost £10.5 million, including expenses and VAT. We are informed by Monitor that this second phase included a team of up to 50 people, which was required to continue to help run the hospital and implement the TSA’s recommendations.</p><p> </p><p> </p><p> </p><p>We are also informed by Monitor that trust special administration at Mid-Staffordshire NHS Trust amounted to the rounded figure of 10,900 person-days for teams working on both phases of the process.</p><p> </p><p> </p><p> </p><p>In the table below, expenses incurred during the TSA process are split by the two phases of the TSA and totals are also provided. These expenses include:</p><p> </p><p> </p><p> </p><p>(a) accommodation;</p><p> </p><p>(b) travel (car, taxi and train);</p><p> </p><p>(c) subsistence; and</p><p> </p><p>(d) other expenses incurred; and what other costs to the TSA were incurred</p><p> </p><p> </p><p> </p><p>Breakdown of expenses, these exclude VAT:</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td><p>TSA1</p></td><td><p>TSA2</p></td><td><p>Total</p></td></tr><tr><td><p>Accommodation</p></td><td><p>£82,242.89</p></td><td><p>£170,622.67</p></td><td><p>£252,865.56</p></td></tr><tr><td><p>Travel</p></td><td><p>£144,122.38</p></td><td><p>£226,600.29</p></td><td><p>£370,722.67</p></td></tr><tr><td><p>Subsistence</p></td><td><p>£16,171.73</p></td><td><p>£43,176.88</p></td><td><p>£59,348.61</p></td></tr><tr><td><p>Other (incidentals such as printing, room hire and meeting refreshments)</p></td><td><p>£1,939.11</p></td><td><p>£3052.73</p></td><td><p>£4991.84</p></td></tr><tr><td><p>Total</p></td><td><p>£244,476.11</p></td><td><p>£443,452.57</p></td><td><p>£687,928.68</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 10/03/2015 17:13:10 question first ministerially corrected 17/03/2015 17:12:17 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 49061 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	4109 label Biography information for Jeremy Lefroy

224727

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hospitals: West Midlands
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much his Department has provided to implement the recommendations of the Trust Special Administration of Mid-Staffordshire NHS Foundation Trust on (a) capital investment in Stafford Hospital, (b) capital investment in Royal Stoke University Hospital, (c) capital investment in Cannock Hospital, (d) capital investment in New Cross Hospital, (e) other capital investment, (f) revenue support for the University Hospitals of the North Midlands NHS Trust, (g) revenue support for the Royal Wolverhampton Hospitals Trust and (h) other revenue support.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	226012
	answer	answer is ministerial correction date of answer 10/03/2015 answer text <p>The Department holds records of the total capital allocated to the respective recipient bodies as a result of the transfer of Mid-Staffordshire NHS Foundation Trust services but does not have details of the breakdown by individual hospital site.</p><p> </p><p> </p><p> </p><p>The capital provided to date is as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>The Royal Wolverhampton NHS Trust</p></td><td><p>£12,109,000</p></td></tr><tr><td><p>University Hospitals of North Midlands NHS Trust</p></td><td><p>£12,153,000</p></td></tr><tr><td><p>Walsall Healthcare NHS Trust</p></td><td><p>£4,000,000</p></td></tr><tr><td><p>Grand Total</p></td><td><p>£28,262,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Revenue funding provided to date is set out in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p><del class="ministerial">The Royal Wolverhampton NHS Trust</del></p><p><ins class="ministerial">University Hospitals of North Midlands NHS Trust</ins></p></td><td><p>£32,420,000</p></td></tr><tr><td><p><del class="ministerial">University Hospitals of North Midlands NHS Trust</del></p><p><ins class="ministerial">The Royal Wolverhampton NHS Trust</ins></p></td><td><p>£5,480,000</p></td></tr><tr><td><p>Grand Total</p></td><td><p>£37,900,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The amount of public dividend capital issued to the Trust by the Department is as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>2009/10</p></td><td><p>£214,000</p></td></tr><tr><td><p>2010/11</p></td><td><p>£0</p></td></tr><tr><td><p>2011/12</p></td><td><p>£21,000,000</p></td></tr><tr><td><p>2012/13</p></td><td><p>£21,385,000</p></td></tr><tr><td><p>2013/14</p></td><td><p>£30,397,000</p></td></tr><tr><td><p>2014/15</p></td><td><p>£64,425,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The Department does not hold central records of non-tariff payments made by local commissioning bodies to NHS providers.</p><p> </p><p> </p><p> </p><p>The work of the trust special administrators (TSAs) to secure safe and sustainable services at Mid Staffordshire NHS Trust cost Monitor almost £19.5 million, including VAT, over 18 months.</p><p> </p><p> </p><p> </p><p>The first phase of trust special administration cost £9 million, including expenses and VAT. During this phase there was a team of up to 30 members of staff who carried out three core tasks - to help to run the Trust, to design the future of services provided at Stafford and Cannock hospitals, and to run a large public consultation involving thousands of responses and a series of public meetings.</p><p> </p><p> </p><p> </p><p>The second phase cost £10.5 million, including expenses and VAT. We are informed by Monitor that this second phase included a team of up to 50 people, which was required to continue to help run the hospital and implement the TSA’s recommendations.</p><p> </p><p> </p><p> </p><p>We are also informed by Monitor that trust special administration at Mid-Staffordshire NHS Trust amounted to the rounded figure of 10,900 person-days for teams working on both phases of the process.</p><p> </p><p> </p><p> </p><p>In the table below, expenses incurred during the TSA process are split by the two phases of the TSA and totals are also provided. These expenses include:</p><p> </p><p> </p><p> </p><p>(a) accommodation;</p><p> </p><p>(b) travel (car, taxi and train);</p><p> </p><p>(c) subsistence; and</p><p> </p><p>(d) other expenses incurred; and what other costs to the TSA were incurred</p><p> </p><p> </p><p> </p><p>Breakdown of expenses, these exclude VAT:</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td><p>TSA1</p></td><td><p>TSA2</p></td><td><p>Total</p></td></tr><tr><td><p>Accommodation</p></td><td><p>£82,242.89</p></td><td><p>£170,622.67</p></td><td><p>£252,865.56</p></td></tr><tr><td><p>Travel</p></td><td><p>£144,122.38</p></td><td><p>£226,600.29</p></td><td><p>£370,722.67</p></td></tr><tr><td><p>Subsistence</p></td><td><p>£16,171.73</p></td><td><p>£43,176.88</p></td><td><p>£59,348.61</p></td></tr><tr><td><p>Other (incidentals such as printing, room hire and meeting refreshments)</p></td><td><p>£1,939.11</p></td><td><p>£3052.73</p></td><td><p>£4991.84</p></td></tr><tr><td><p>Total</p></td><td><p>£244,476.11</p></td><td><p>£443,452.57</p></td><td><p>£687,928.68</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 10/03/2015 17:13:10 question first ministerially corrected 17/03/2015 16:58:03 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 49059 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	4109 label Biography information for Jeremy Lefroy

224870

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Billing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what proportion of undisputed invoices his Department and its agencies and non-departmental public bodies paid within five days in the last period for which figures are available.
	tabling member constituency	Streatham
	tabling member printed	Mr Chuka Umunna
	uin	226077
	answer	answer is ministerial correction date of answer 10/03/2015 answer text <p>The last period for which complete figures are available is the 2013-14 financial-year i.e. 12 months ended 31 March 2014. The table below details the proportion (%) of undisputed payments made, by individual body:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Body</p></td><td><p>Proportion of invoices paid within 5 days</p><p>(% to nearest 1%)</p></td></tr><tr><td><p>Department of Health</p></td><td><p>95</p></td></tr><tr><td><p>Medicines and Healthcare Products Regulatory Agency</p></td><td><p>76</p></td></tr><tr><td><p>Human Tissue Authority</p></td><td><p>95</p></td></tr><tr><td><p>Monitor</p></td><td><p><del class="ministerial">92</del><ins class="ministerial">0*</ins></p></td></tr><tr><td><p>Public Health England</p></td><td><p>81</p></td></tr><tr><td><p>Care Quality Commission</p></td><td><p>89</p></td></tr><tr><td><p>NHS Litigation Authority</p></td><td><p>13</p></td></tr><tr><td><p>Health Education England</p></td><td><p>2</p></td></tr><tr><td><p>Health Research Authority</p></td><td><p>6</p></td></tr><tr><td><p>Health and Social Care Information Centre</p></td><td><p>16</p></td></tr><tr><td><p>National Institute for Health &amp; Care Excellence</p></td><td><p>6</p></td></tr><tr><td><p>NHS Blood and Transplant</p></td><td><p>24</p></td></tr><tr><td><p>NHS Property Services</p></td><td><p>0</p></td></tr><tr><td><p>NHS Business Services Authority</p></td><td><p>24</p></td></tr><tr><td><p>NHS England</p></td><td><p>54</p></td></tr></tbody></table><p><ins class="ministerial">*Monitor return is 0% because it works towards paying all valid invoices within 10 working days not five. The 10-day compliance for 2013-14 was 92%.</ins></p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 10/03/2015 16:36:28 question first ministerially corrected 16/03/2015 17:31:17 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 49032 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	4128 label Biography information for Chuka Umunna

164499

	registered interest
	date	24/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Negligence
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government by how much the provision for clinical negligence claims against the National Health Service has grown in the last year; why it has grown; and what strategy is in place for reducing that amount.
	tabling member printed	Lord Sharkey
	uin	HL3092
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>As at 31 March 2014, the National Health Service Litigation Authority (NHS LA) estimates that it has potential liabilities of £26.1 billion, of which £25.7 billion relates to clinical negligence. This is an increase of £3.1 billion from 31 March 201<del class="ministerial">4<ins class="ministerial">3</ins></del>, which can mainly be attributed to a continual rise in clinical negligence claims over recent years. There are a number of factors driving this increase, including the rise in the number of patients cared for and in the complexity of their care; and the general rise in litigation across a number of sectors including the NHS, driven in part by ‘no win, no fee’ agreements. It is anticipated that the effect of the latter is likely to diminish as a result of the Government’s Legal Aid Sentencing and Punishment of Offenders Act of 2012.</p><p> </p><p>The Department believes the best way to reduce negligence claims is to improve patient care and safety. In March 2014, the Secretary of State for Health issued a call to action to make the NHS the safest healthcare system in the world and achieve a three-year goal to halve avoidable harm and save 6,000 lives. The Sign up to Safety campaign embodies the ambition of the NHS to build a culture of safety, bringing together individuals and organisations with a contribution to make towards the patient safety goal. Elements of this campaign will focus on a reduction in avoidable harm that can lead to compensation claims. Organisations that sign up are setting out what they will do to strengthen patient safety, including a safety improvement plan which shows how their organisation intends to save lives and reduce harm for patients over the next three years. The NHS Litigation Authority, which already provides a “safety and learning service” to trusts<strong>,</strong> will support those organisations which have patient safety improvement plans that show a likely reduction in their higher volume, higher value claims.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 16:04:05 question first ministerially corrected 13/01/2015 14:37:59 answering member 2000 label Biography information for Earl Howe previous answer version 31769 answering member printed Earl Howe answering member 2000 label Biography information for Earl Howe
	tabling member	4196 label Biography information for Lord Sharkey

177981

	registered interest
	date	04/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Passive Smoking
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what is their estimate of the number of people who died as a result of passive smoking in each of the last five years.
	tabling member printed	Lord Laird
	uin	HL4692
	answer	answer is ministerial correction date of answer 17/02/2015 answer text <p>Exposure to secondhand smoke is a serious health hazard. More than 50 carcinogens have been identified in secondhand smoke.</p><p> </p><p> </p><p> </p><p>The report of the United States Surgeon General titled “<em>The health consequences of involuntary exposure to tobacco smoke”</em> concluded that secondhand smoke causes premature death and disease in children and adults who do not smoke. The scientific evidence indicates that there is no risk-free level of exposure to secondhand smoke. Children exposed to secondhand smoke are at an increased risk for sudden infant death syndrome, acute respiratory infections, ear problems and more severe asthma. Smoking by parents causes respiratory symptoms and slows lung growth in children. Exposure of adults to secondhand smoke has immediate adverse effects on the cardiovascular system and causes coronary heart disease and lung cancer. Legislation to stop smoking in vehicles carrying children will come into force in England on 1 October 2015.</p><p> </p><p><br /> The report of the Royal College of <ins class="ministerial">Physicians </ins><del class="ministerial">Surgeons</del> titled “<em>Going smoke-free: The medical case for clean air in the home, at work and in public places”</em> included estimates that secondhand smoke exposure caused approximately 12<del class="ministerial">2</del>,200 deaths in the United Kingdom in 2003, and that the majority of these deaths occurred as a result of exposure to secondhand smoke in the home. These estimates were made prior to the introduction of smokefree legislation in England in 2007. Over the past decade, the proportion of smokers who say that they do not smoke in the home has increased.</p><p> </p><p> </p><p> </p><p>The evidence is clear that smokefree legislation in England has had beneficial effects on health, as set out in the report “<em>The Impact of smokefree legislation in England: evidence review”</em> which was published alongside the Government’s <em>“Tobacco Control Plan for England”</em> in March 2011.</p><p> </p><p> </p><p> </p><p>The reports referred to have been placed in the Library.</p><p> </p> answering member printed Earl Howe question first answered 17/02/2015 16:08:25 question first ministerially corrected 12/03/2015 12:34:25 answering member 2000 label Biography information for Earl Howe previous answer version 45462 answering member printed Earl Howe answering member 2000 label Biography information for Earl Howe
	tabling member	2479 label Biography information for Lord Laird

100721

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Osteoporosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211732
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall

100723

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Motor Neurone Disease: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to prevent or treat symptoms of motore neurone disease in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211734
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall

100728

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Motor Neurone Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much from the public purse has been spent on research into motor neurone disease in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211730
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall

100730

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Osteoporosis: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to treat symptoms of osteoporosis in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211735
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall

100885

	registered interest
	date	24/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Asthma: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much the Government has spent on the development of new drugs to treat the symptoms of asthma in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211885
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:29 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall

100887

	registered interest
	date	24/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Asthma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much public funding was allocated to research into asthma in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211918
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall

224735

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups: Cumbria
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what funding (a) in total and (b) per capita has been allocated for Cumbria Clinical Commissioning Group for each year from 2013-14 to 2019-20.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	226114
	answer	answer is ministerial correction date of answer 06/03/2015 answer text <p>Clinical commissioning group (CCG) funding has not been decided beyond 2015/16. Notified revenue allocations and per capita allocations for Cumbria CCG are:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Allocation £000</p></td><td><p>Per capita £</p></td></tr><tr><td><p>2013/14</p></td><td><p><del class="ministerial">692,122</del></p><p><ins class="ministerial">663,133</ins></p></td><td><p><del class="ministerial">1,330</del></p><p><ins class="ministerial">1,274</ins></p></td></tr><tr><td><p>2014/15</p></td><td><p>677,324</p></td><td><p>1,299</p></td></tr><tr><td><p>2015/16</p></td><td><p>685,654</p></td><td><p>1,313</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>These figures exclude running cost and Better Care Fund allocations.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 06/03/2015 14:39:07 question first ministerially corrected 19/03/2015 18:02:16 answering member 4020 label Biography information for George Freeman previous answer version 48371 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	1503 label Biography information for Mr Jamie Reed

167080

	registered interest
	date	01/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much the NHS spends on sickle cell anaemia; and what proportion this is of the total NHS budget.
	tabling member constituency	Wolverhampton South East
	tabling member printed	Mr Pat McFadden
	uin	216527
	answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>There are an estimated 250,000 people with <ins class="ministerial">the</ins> sickle cell <ins class="ministerial">trait</ins> <del class="ministerial">anaemia</del> in the United Kingdom. The Department has made no estimation of the annual cost of treating sickle cell anaemia in the National Health Service nor does it hold information on the total NHS spend on sickle cell anaemia.</p><p> </p><p> </p><p> </p><p>The Department does hold estimated costs for admitted patient care episodes as reported by Healthcare Resource Groups. In 2013-14 the total estimated figure for sickle anaemia was £23.8 million; in 2012-13 it was £21.9 million. This figure does not include other costs such as primary and social care.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/12/2014 15:12:22 question first ministerially corrected 10/12/2014 16:29:44 answering member 3918 label Biography information for Jane Ellison previous answer version 32239 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	1587 label Biography information for Pat McFadden

167082

	registered interest
	date	01/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the annual cost to the NHS of treating sickle cell anaemia.
	tabling member constituency	Wolverhampton South East
	tabling member printed	Mr Pat McFadden
	uin	216529
	answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>There are an estimated 250,000 people with <ins class="ministerial">the</ins> sickle cell <ins class="ministerial">trait</ins> <del class="ministerial">anaemia</del> in the United Kingdom. The Department has made no estimation of the annual cost of treating sickle cell anaemia in the National Health Service nor does it hold information on the total NHS spend on sickle cell anaemia.</p><p> </p><p> </p><p> </p><p>The Department does hold estimated costs for admitted patient care episodes as reported by Healthcare Resource Groups. In 2013-14 the total estimated figure for sickle anaemia was £23.8 million; in 2012-13 it was £21.9 million. This figure does not include other costs such as primary and social care.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/12/2014 15:12:22 question first ministerially corrected 10/12/2014 16:29:44 answering member 3918 label Biography information for Jane Ellison previous answer version 32239 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	1587 label Biography information for Pat McFadden

168663

	registered interest
	date	08/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many women were referred onwards to other care pathways after it was determined that they were being coerced into seeking an abortion in the last year for which records are available.
	tabling member constituency	Calder Valley
	tabling member printed	Craig Whittaker
	uin	217763
	answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The Department does <ins class="ministerial">not </ins>hold this information.</p><p> </p><p> </p><p> </p><p>We take the issue of coercion seriously and staff working in abortion clinics are experienced and highly skilled in discussing sensitive issues with women and identifying whether there is any coercion or other risks to the woman.</p><p> </p><p> </p><p> </p><p>Women who present for an abortion will always have the opportunity to speak to a health professional on their own at some point during the consultation. Pathways should be in place to refer women to specialised services if coercion is identified.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/12/2014 16:55:05 question first ministerially corrected 15/12/2014 17:10:17 answering member 3918 label Biography information for Jane Ellison previous answer version 33588 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	3940 label Biography information for Craig Whittaker

168664

	registered interest
	date	08/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many abortions were refused on the grounds on coercion in the last year for which records are available.
	tabling member constituency	Fylde
	tabling member printed	Mark Menzies
	uin	217766
	answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The Department does <ins class="ministerial">not </ins>hold this information.</p><p> </p><p> </p><p> </p><p>We take the issue of coercion seriously and staff working in abortion clinics are experienced and highly skilled in discussing sensitive issues with women and identifying whether there is any coercion or other risks to the woman.</p><p> </p><p> </p><p> </p><p>Women who present for an abortion will always have the opportunity to speak to a health professional on their own at some point during the consultation. Pathways should be in place to refer women to specialised services if coercion is identified.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/12/2014 16:55:05 question first ministerially corrected 15/12/2014 17:10:17 answering member 3918 label Biography information for Jane Ellison previous answer version 33589 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	3998 label Biography information for Mark Menzies

175097

	registered interest
	date	21/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hospital Beds: North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many delayed discharges there were from (a) St Helens and Knowsley Hospitals Trust and (b) Warrington and Halton Hospitals NHS Foundation Trust in each month since January 2014.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	221512
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p>Information is not available in the format requested. The data that is available is shown in the following tables.</p><p> </p><p> </p><p> </p><p>Table 1: St Helens and Knowsley Hospitals NHS Trust</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Month</p></td><td><p>Patients</p></td><td><p>Days</p></td><td> </td></tr><tr><td><p>January 2014</p></td><td><p>8</p></td><td><p>282</p></td><td> </td></tr><tr><td><p>February 2014</p></td><td><p>5</p></td><td><p>233</p></td><td> </td></tr><tr><td><p>March 2014</p></td><td><p>5</p></td><td><p>253</p></td><td> </td></tr><tr><td><p>April 2014</p></td><td><p>3</p></td><td><p>186</p></td><td> </td></tr><tr><td><p>May 2014</p></td><td><p>7</p></td><td><p>188</p></td><td> </td></tr><tr><td><p>June 2014</p></td><td><p>7</p></td><td><p>158</p></td><td> </td></tr><tr><td><p>July 2014</p></td><td><p>4</p></td><td><p>227</p></td><td> </td></tr><tr><td><p>August 2014</p></td><td><p>4</p></td><td><p>155</p></td><td> </td></tr><tr><td><p>September 2014</p></td><td><p>3</p></td><td><p>166</p></td><td> </td></tr><tr><td><p>October 2014</p></td><td><p>5</p></td><td><p>186</p></td><td> </td></tr><tr><td><p>November 2014</p></td><td><p>3</p></td><td><p>143</p></td><td> </td></tr><tr><td><p>December 2014</p></td><td><p>3</p></td><td><p>149</p></td><td> </td></tr><tr><td> </td><td colspan="3"> </td></tr></tbody></table><p> </p><p><em>Source</em>: NHS England</p><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><ol start="1" type="1"><li>Patients: The number of patients whose transfer is delayed at midnight on the last Thursday of the month.</li><li>Days: The number of days delayed within the month for all patients delayed throughout the month.</li></ol><p> </p><p> </p><p> </p><p> </p><p> </p><p>Table 2: Warrington and Halton Hospitals NHS Foundation Trust</p><p> </p><table><tbody><tr><td colspan="3"> </td></tr><tr><td><p>Month</p></td><td><p>Patients</p></td><td><p>Days</p></td></tr><tr><td><p>January 2014</p></td><td><p>20</p></td><td><p>407</p></td></tr><tr><td><p>February 2014</p></td><td><p>19</p></td><td><p>591</p></td></tr><tr><td><p>March 2014</p></td><td><p>16</p></td><td><p>535</p></td></tr><tr><td><p>April 2014</p></td><td><p>26</p></td><td><p>513</p></td></tr><tr><td><p>May 2014</p></td><td><p>24</p></td><td><p>548</p></td></tr><tr><td><p>June 2014</p></td><td><p>14</p></td><td><p>537</p></td></tr><tr><td><p>July 2014</p></td><td><p>20</p></td><td><p>688</p></td></tr><tr><td><p>August 2014</p></td><td><p>26</p></td><td><p>880</p></td></tr><tr><td><p>September 2014</p></td><td><p>24</p></td><td><p>576</p></td></tr><tr><td><p>October 2014</p></td><td><p>20</p></td><td><p>458</p></td></tr><tr><td><p>November 2014</p></td><td><p>9</p></td><td><p>425</p></td></tr><tr><td><p>December 2014</p></td><td><p>11</p></td><td><p>222</p></td></tr><tr><td> </td><td colspan="2"> </td></tr></tbody></table><p> </p><p><em>Source</em>: NHS England</p><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><ol start="1" type="1"><li>Patients: The number of patients whose transfer is delayed at midnight on the last Thursday of the month.</li><li>Days: The number of days delayed within the month for all patients delayed throughout the month.</li></ol><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 26/01/2015 16:57:42 question first ministerially corrected 26/01/2015 17:14:04 answering member 1439 label Biography information for Norman Lamb previous answer version 41239 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	429 label Biography information for Derek Twigg

176781

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether joint committees of NHS England and clinical commissioning groups are permitted to deviate from national service specifications for specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222695
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:20:37 answering member 3918 label Biography information for Jane Ellison previous answer version 42619 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

176783

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when NHS England will publish details of the co-commissioning of specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222693
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:21:10 answering member 3918 label Biography information for Jane Ellison previous answer version 42620 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

176784

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether NHS England will remain the sole budget-holder and accountable commissioner for all specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222694
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:23:29 answering member 3918 label Biography information for Jane Ellison previous answer version 42621 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

178160

	registered interest
	date	05/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Heart Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many admissions to hospital with a (a) primary and (b) secondary diagnosis of coronary heart disease per head of population there were in (i) each clinical commissioning group and its predecessor organisation and (ii) England in each of the last 10 years.
	tabling member constituency	Sutton and Cheam
	tabling member printed	Paul Burstow
	uin	223598
	answer	answer is ministerial correction date of answer 12/02/2015 answer text <p>The following tables show the number of admissions to hospital with a primary and secondary diagnosis of coronary heart disease by primary care trust of treatment for the years 2004/05 to 2012/13; by clinical commissioning group of treatment for 2013/14 and for England as a whole.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/02/2015 15:52:16 question first ministerially corrected 12/02/2015 16:09:16 answering member 3918 label Biography information for Jane Ellison attachment 1 file name Hospital Admissions data.xlsx title No. of adnissions - CHD previous answer version 45133 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	204 label Biography information for Paul Burstow

171266

	registered interest
	date	17/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Social Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the (a) actual and (b) percentage change was in expenditure per head of population aged 65 and over on adult social care services in each English local authority in 2009-10 and 2013-14.
	tabling member constituency	Westminster North
	tabling member printed	Ms Karen Buck
	uin	219191
	answer	answer is ministerial correction date of answer 05/01/2015 answer text <p><del class="ministerial">Data on expenditure per head of population aged 65 and over on adult social care services is not held centrally and could only be obtained at disproportionate cost. The attached table provides the net current expenditure per head of population who receive adult social care aged 65 and over, broken down by local authority and year. The last column shows the percentage change between 2009-10 and 2013-14.</del></p><p> </p><p><ins class="ministerial">Local authorities in England spent £6.7 billion on social care for people aged over 65 and over in 2013-14, compared with £7.4 billion in 2009-10. In 2013-14 the National Health Service transferred £859 million to social care but we are unable to include this investment in the overall spending figure as we do not hold information on how much of it was spent on people aged 65 and over.</ins></p><p><ins class="ministerial">The attached table provides a breakdown of expenditure on social care per head of population aged 65 and over broken down by local authority in 2009-10 and 2013-14. The table also details the percentage change and actual change between those two financial years. The figures do not include NHS transfer funding.</ins></p><p><ins class="ministerial"> <p> </p><p> </p><p /> <p> </p></ins></p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 05/01/2015 16:21:02 question first ministerially corrected 13/01/2015 14:57:52 answering member 1439 label Biography information for Norman Lamb attachment 1 file name Revised table PQ 219191.docx title Social care spend per head of population 2009-14 previous answer version 36913 answering member constituency North Norfolk answering member printed Norman Lamb answering member 1439 label Biography information for Norman Lamb attachment 1 file name 2014-12-22 PQ219191 Karen Buck Table on over 65 LA Expenditure.docx title Over 65 LA expenditure
	tabling member	199 label Biography information for Ms Karen Buck

174220

	registered interest
	date	16/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accident and Emergency Departments: Greater Manchester
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that hospitals in Greater Manchester meet the Government's A&E waiting time target.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	221094
	answer	answer is ministerial correction date of answer 23/01/2015 answer text <p>My Rt. hon. Friend the Secretary of State meets NHS England on a weekly basis and discusses a wide range of topics, including accident and emergency (A&amp;E) performance data. Monitor, the Care Quality Commission, and the NHS Trust Development Authority also have oversight of trust A&amp;E performance, and are involved in these meetings.</p><p> </p><p> </p><p> </p><p>On the back of a strong economy the Government has made £700 million – the highest ever figure – available to the NHS specifically to help with winter pressures. The first tranche of this money was made available earlier than ever.</p><p> </p><p> </p><p> </p><p>Local plans to spend this money provide for nearly 8,800 extra staff and almost 6,500 extra beds. Over £25 million is going towards increasing access to general practitioners (GPs), including later and weekend appointments. £50 million will help ambulance services meet rising demand for emergency cases and a separate fund of £250 million will support an extra 100,000 operations so people can be seen quicker and before they need to be admitted as an emergency case.</p><p> </p><p> </p><p> </p><p>This money will also support a range of local initiatives to improve urgent and emergency care including seven day pharmacy services, improvements to NHS 111 and GP out of hours services, short stay units for elderly patients and improvements to hospital discharge processes.</p><p> </p><p> </p><p> </p><p>Across Greater Manchester £30 million has been provided with local plans for this to fund over 70 doctors, 300 nurses and 200 extra beds. Clinical commissioning groups in Greater Manchester, as system leaders, are working with NHS England and local partners including local authorities to implement local winter initiatives.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/01/2015 13:51:02 question first ministerially corrected 23/01/2015 14:02:22 answering member 3918 label Biography information for Jane Ellison previous answer version 39987 answering member constituency North Norfolk answering member printed Norman Lamb answering member 1439 label Biography information for Norman Lamb
	tabling member	1506 label Biography information for Andrew Gwynne

174221

	registered interest
	date	16/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accident and Emergency Departments: Greater Manchester
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what discussions his Department has had with local authorities in Greater Manchester on increased attendances in A&E over the winter and delayed discharges.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	221095
	answer	answer is ministerial correction date of answer 23/01/2015 answer text <p>My Rt. hon. Friend the Secretary of State meets NHS England on a weekly basis and discusses a wide range of topics, including accident and emergency (A&amp;E) performance data. Monitor, the Care Quality Commission, and the NHS Trust Development Authority also have oversight of trust A&amp;E performance, and are involved in these meetings.</p><p> </p><p> </p><p> </p><p>On the back of a strong economy the Government has made £700 million – the highest ever figure – available to the NHS specifically to help with winter pressures. The first tranche of this money was made available earlier than ever.</p><p> </p><p> </p><p> </p><p>Local plans to spend this money provide for nearly 8,800 extra staff and almost 6,500 extra beds. Over £25 million is going towards increasing access to general practitioners (GPs), including later and weekend appointments. £50 million will help ambulance services meet rising demand for emergency cases and a separate fund of £250 million will support an extra 100,000 operations so people can be seen quicker and before they need to be admitted as an emergency case.</p><p> </p><p> </p><p> </p><p>This money will also support a range of local initiatives to improve urgent and emergency care including seven day pharmacy services, improvements to NHS 111 and GP out of hours services, short stay units for elderly patients and improvements to hospital discharge processes.</p><p> </p><p> </p><p> </p><p>Across Greater Manchester £30 million has been provided with local plans for this to fund over 70 doctors, 300 nurses and 200 extra beds. Clinical commissioning groups in Greater Manchester, as system leaders, are working with NHS England and local partners including local authorities to implement local winter initiatives.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/01/2015 13:51:02 question first ministerially corrected 23/01/2015 14:02:55 answering member 3918 label Biography information for Jane Ellison previous answer version 39989 answering member constituency North Norfolk answering member printed Norman Lamb answering member 1439 label Biography information for Norman Lamb
	tabling member	1506 label Biography information for Andrew Gwynne

174223

	registered interest
	date	16/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accident and Emergency Departments: Greater Manchester
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what discussions he has had with Monitor, the Care Quality Commission and NHS England on hospitals in Greater Manchester which have not met the Government's A&E waiting time target.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	221081
	answer	answer is ministerial correction date of answer 23/01/2015 answer text <p>My Rt. hon. Friend the Secretary of State meets NHS England on a weekly basis and discusses a wide range of topics, including accident and emergency (A&amp;E) performance data. Monitor, the Care Quality Commission, and the NHS Trust Development Authority also have oversight of trust A&amp;E performance, and are involved in these meetings.</p><p> </p><p> </p><p> </p><p>On the back of a strong economy the Government has made £700 million – the highest ever figure – available to the NHS specifically to help with winter pressures. The first tranche of this money was made available earlier than ever.</p><p> </p><p> </p><p> </p><p>Local plans to spend this money provide for nearly 8,800 extra staff and almost 6,500 extra beds. Over £25 million is going towards increasing access to general practitioners (GPs), including later and weekend appointments. £50 million will help ambulance services meet rising demand for emergency cases and a separate fund of £250 million will support an extra 100,000 operations so people can be seen quicker and before they need to be admitted as an emergency case.</p><p> </p><p> </p><p> </p><p>This money will also support a range of local initiatives to improve urgent and emergency care including seven day pharmacy services, improvements to NHS 111 and GP out of hours services, short stay units for elderly patients and improvements to hospital discharge processes.</p><p> </p><p> </p><p> </p><p>Across Greater Manchester £30 million has been provided with local plans for this to fund over 70 doctors, 300 nurses and 200 extra beds. Clinical commissioning groups in Greater Manchester, as system leaders, are working with NHS England and local partners including local authorities to implement local winter initiatives.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/01/2015 13:51:02 question first ministerially corrected 23/01/2015 14:02:44 answering member 3918 label Biography information for Jane Ellison previous answer version 39988 answering member constituency North Norfolk answering member printed Norman Lamb answering member 1439 label Biography information for Norman Lamb
	tabling member	1506 label Biography information for Andrew Gwynne

222966

	registered interest
	date	23/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he expects that the Child and Adolescent Mental Health Services Dataset will start publishing data; and if he will make a statement.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	225018
	answer	answer is ministerial correction date of answer 26/02/2015 answer text <p><ins class="ministerial">The Health and Social Care Information Centre advise that the collection of data for the Child and Adolescent Mental Health Services dataset will start at the beginning of February 2016. The first submission period will cover January to March 2016. Statistical reports based on the initial data collection will be published in mid-2016.</ins></p><p> </p><p> </p><p> </p><p><del class="ministerial">The National Institute for Health and Care Excellence guidance <em>Multiple sclerosis: management of multiple sclerosis in primary and secondary care</em>, updated in October 2014, sets out best practice on the diagnosis, treatment, care and support of people with multiple sclerosis (MS). The guidance makes a range of recommendations on drug based treatments for MS, but also highlights the importance of involving professionals who can meet the needs of the patient in the best way, such as physiotherapists and occupational therapists. </del></p><p> </p><p> </p><p><ins class="ministerial"></ins></p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><del class="ministerial">With regard to early diagnosis, MS is a difficult condition to diagnose as a number of the symptoms such as fatigue, depression or dizziness may be unrelated. The guidance sets out a number of initial presentations that clinicians should be aware of when looking for signs of MS. It also recommends a number of assessments a clinician should make, including testing of vision and blood tests before referral to a consultant neurologist, who can confirm or exclude a diagnosis of MS, subject to investigation.</del></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 26/02/2015 15:20:43 question first ministerially corrected 27/02/2015 13:56:12 answering member 1439 label Biography information for Norman Lamb previous answer version 46777 answering member constituency North Norfolk answering member printed Norman Lamb answering member 1439 label Biography information for Norman Lamb
	tabling member	4036 label Biography information for Luciana Berger